Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia

被引:64
作者
Antachopoulos, Charalampos [1 ]
Meletiadis, Joseph [1 ]
Sein, Tin [1 ]
Roilides, Emmanuel [1 ,2 ]
Walsh, Thomas J. [1 ]
机构
[1] NCI, CRC, Pediat Oncol Branch, Immunocompromised Host Sect, Bethesda, MD 20892 USA
[2] Aristotle Univ Thessaloniki, Hippokrat Hosp, Dept Pediat 3, Thessaloniki, Greece
关键词
D O I
10.1128/AAC.00699-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The concentration-dependent effects of echinocandins on the metabolic activity of Aspergillus spp. were comparatively studied by using nongerminated and germinated conidia. The susceptibilities of 11 Aspergillus fumigatus, 8 A. terreus and 8 A. flavus isolates to caspofungin, micafungin, and anidulafungin were studied by a CLSI (formerly NCCLS) M38-A broth microdilution-based method. After 48 h of incubation the minimum effective concentration (MEC) was defined microscopically. Metabolic activity was assessed by the 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide assay and modeled by using the sigmoid (E(max)) or "bell-shaped" model. The median MEC values of caspofungin (0.5 to 1 mu g/ml), micafungin (0.06 to 0.12 mu g/ml), and anidulafungin (0.03 mu g/ml) against nongerminated conidia increased by 0 to 1, 1 to 2, and 2 to 3 twofold dilutions, respectively (depending on the species), over those against germinated conidia. A similar shift to the right was demonstrated for the corresponding curves of metabolic activity. There was a significant correlation between the degrees of maximal metabolic inhibition caused by different echinocandins at both the species level (greater inhibition for A. flavus) and the strain level (r = 0.84 to 0.93; P < 0.0001). Paradoxical increases in metabolism in the presence of higher concentrations of caspofungin, micafungin, and anidulafungin were detected in 6, 2, and 5 of the A. fumigatus isolates, respectively; 5, 1, and 2 of the A. terreus isolates, respectively; and 1, 0, and 0 of the A. flavus isolates, respectively. Based on the model, 50% of the maximal paradoxical increase was detected with 4.2, 11.1, and 10.8 p,mu g/ml of caspofungin, micafungin, and anidulafungin, respectively. All echinocandins therefore exerted comparable levels of maximal metabolic inhibition against Aspergillus spp. at concentrations that were differentially increased for germinated versus nongerminated conidia. The paradoxical increase in metabolism occurred more frequently and at lower concentrations with caspofungin than with micafungin and anidulafungin.
引用
收藏
页码:321 / 328
页数:8
相关论文
共 33 条
[1]   Use of high inoculum for early metabolic signalling and rapid susceptibility testing of Aspergillus species [J].
Antachopoulos, Charalampos. ;
Meletiadis, Joseph ;
Sein, Tin ;
Roilides, Emmanuel ;
Walsh, Thomas J. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (02) :230-237
[2]   Concentration-dependent effects of caspofungin on the metabolic activity of Aspergillus species [J].
Antachopoulos, Charalampos ;
Meletiadis, Joseph ;
Sein, Tin ;
Roilides, Emmanuel ;
Walsh, Thomas J. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (03) :881-887
[3]   In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates [J].
Arikan, S ;
Lozano-Chiu, M ;
Paetznick, V ;
Rex, JH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) :327-330
[4]   Efficacy of caspofungin against Aspergillus flavus, Aspergillus terreus, and Aspergillus nidulans [J].
Bowman, J. C. ;
Abruzzo, G. K. ;
Flattery, A. M. ;
Gill, C. J. ;
Hickey, E. J. ;
Hsu, M. J. ;
Kahn, J. Nielsen ;
Liberator, P. A. ;
Misura, A. S. ;
Pelak, B. A. ;
Wang, T. C. ;
Douglas, C. M. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (12) :4202-4205
[5]   Collaboration of human phagocytes with LY 303366 for antifungal activity against Aspergillus fumigatus [J].
Brummer, E ;
Chauhan, SD ;
Stevens, DA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (04) :491-496
[6]   Interaction between posaconazole and caspofungin in concomitant treatment of mice with systemic Aspergillus infection [J].
Cacciapuoti, A ;
Halpern, J ;
Mendrick, C ;
Norris, C ;
Patel, R ;
Loebenberg, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (07) :2587-2590
[7]   Paradoxical effect of echinocandins across Candida species in vitro:: Evidence for echinocandin-specific and Candida species-related differences [J].
Chamilos, Georgios ;
Lewis, Russell E. ;
Albert, Nathaniel ;
Kontoyiannis, Dimitrios P. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (06) :2257-2259
[8]   The interaction of human monocytes, monocyte-derived macrophages, and polymorphonuclear neutrophils with caspofungin (MK-0991), an echinocandin, for antifungal activity against Aspergillus fumigatus [J].
Chiller, T ;
Farrokhshad, K ;
Brummer, E ;
Stevens, DA .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2001, 39 (02) :99-103
[9]   Combined action of micafungin, a new echinocandin, and human phagocytes for antifungal activity against Aspergillus fumigatus [J].
Choi, JH ;
Brummer, E ;
Stevens, DA .
MICROBES AND INFECTION, 2004, 6 (04) :383-389
[10]   Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis [J].
Denning, David W. ;
Marr, Kieren A. ;
Lau, Wendi M. ;
Facklam, David P. ;
Ratanatharathorn, Voravit ;
Becker, Cornelia ;
Ullmann, Andrew J. ;
Seibel, Nita L. ;
Flynn, Patricia M. ;
van Burik, Jo-Anne H. ;
Buell, Donald N. ;
Patterson, Thomas F. .
JOURNAL OF INFECTION, 2006, 53 (05) :337-349